CAS: 42373-30-8; 4-Aminonicotinaldehyde

该化合物是一种有机化合物,其特征为:环,是一个含有一个氮原子的由六人组成的芳香热循环,该化合物的特征为:氨基组(-NH2)和一个附于环的气态组(-CHO),具体在4和3个位置上;这一结构安排有助于其在有机合成和药用化学中的活性和潜在应用;氨基组的存在允许各种衍生反应,而气态组可以参与凝聚反应,使它成为合成更复杂的分子的多用途中间体.4-Amino-3-丙酰胺在室温度上通常是固态的,由于功能组的存在,极地溶剂中可能表现出溶解性.其化学特性,例如再活性和稳定性,可能受到环和环上的亚化物的电子效应的影响.

结构式图片

相似化合物

116026-93-8 16135-36-7 7418-65-7

欧盟法规

ECHA物质C&L通报

上下游产品

N-(3-formylpyridin-4-yl)-2,2-dimethylpropanamide -3-pyridinecarboxaldehyde4--3-pyridinecarboxaldehyde 4-nitro-3-pyridinecarbaldehyde 1-oxide 3-methyl-4-nitropyridine N-oxide 1,6-naphthyridine-2-carboxylic acid 8-bromo-[1,6]-naphthyridine-2-carboxylic acid N-(2-methoxybenzyl)-2-(1,6)naphthyridinecarboxamide

合成工艺路线路线简述

    3-甲基-4-硝基吡啶-N-氧化物置于palladium On Activated Charcoal Sodium Periodate,氢气体系中,用 四氢呋喃,甲醇,水,N,N-二甲基甲酰胺 作为反应溶剂,20.0~150.0 °C,101.33 Kpa 条件下,反应 3.0H,反应生成 4-氨基-3-吡啶甲醛
    参考文献:4-Aminopyridine Derivatives With Antiamnesic Activity
    标题:4-Aminopyridine Derivatives With Antiamnesic Activity
    摘要:Acetylcholine (Ach) Enhancement,Useful In The Treatment Of Alzheimer'S Disease (Ad),May Be Obtained By Means Of Ion Channel Modulators Such As 4-Aminopyridine (4-Ap). 4-Ap Is Also The Central Ring Of Tacrine,The First Drug Approved For The Treatment Of Ad. The Synthesis And Pharmacological Activity Of Three 4-Ap Derivatives,Prepared With The Aim Of Improving Their Antiamnesic Activity,Is Here Described. In Two Of These Compounds 4-Ap Is Connected To 4-Aminobutyric Acid (Gaba),Whereas In The Third It Is Connected To 2-Indolinone,I.E.,The Skeleton Of Linopirdine,Another Ach Enhancing Agent. The New Compounds Showed Potent Antiamnesic Activity In Comparison With Piracetam. (C) 2000 Edition Scientifiques Et Medicales Elsevier Sas.
    DOI:10.1016/s0223-5234(00)00103-3

    海关参考信息

    专利信息


    专利号:US-8188113-B2
    优先权日:2006-09-14
    标 题 :Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
    发明人:FLYNN DANIEL L; PETILLO PETER A; KAUFMAN MICHAEL D; PATT WILLIAM C
    权利人:FLYNN DANIEL L; PETILLO PETER A; KAUFMAN MICHAEL D; PATT WILLIAM C; DECIPHERA PHARMACEUTICALS INC
    摘要:The present invention relates to novel dihydropyridopyrimidinyl, dihydronaphthyridinyl, and related compounds which are kinase inhibitors and modulator useful for the treatment of various diseases. More particularly, the invention is concerned with such compounds, kinase/compound adducts, methods of treating diseases, and methods of synthesis of the compounds. Preferably, the compounds are useful for the modulation of kinase activity of Raf kinases and disease polymorphs thereof. Compounds of the present invention find utility in the treatment of mammalian cancers and especially human cancers including but not limited to malignant melanoma, colorectal cancer, ovarian cancer, papillary thyroid carcinoma, non small cell lung cancer, and mesothelioma. Compounds of the present invention also find utility in the treatment of rheumatoid arthritis and retinopathies including diabetic retinal neuropathy and macular degeneration.

    专利号:US-4894456-A
    优先权日:1987-03-31
    标题 :Synthesis of camptothecin and analogs thereof
    发明人:WALL MONROE E; WANI MANSUKH C; NICHOLAS ALLAN W; MANIKUMAR GOVINDARAJAN
    权利人:RES TRIANGLE INST
    摘要:A method for synthesizing camptothecin and camptothecin analogs using a novel hydroxyl-containing tricyclic intermediate and the camptothecin analogs produced by the process. The camptothecin analogs are effective inhibitors of topoisomerase I and show anti-leukemic and anti-tumor activity.

    专利号:US-4981968-A
    优先权日:1987-03-31
    标题:Synthesis of camptothecin and analogs thereof
    发明人:WALL MONROE E; WANI MANSUKH C; NICHOLAS ALLAN W; MANIKUMAR GOVINDARAJAN
    权利人:RES TRIANGLE INST
    摘要:A method for synthesizing camptothecin and camptothecin analogs using a novel hydroxyl-containing tricyclic intermediate and the camptothecin analogs produced by the process. The camptothecin analogs are effective inhibitors of topoisomerase I and show anti-leukemic and anti-tumor activity.

    专利号:EP-0436653-A4
    优先权日:1988-09-28
    标题 :Synthesis of camptothecin and analogs thereof

    专利号:WO-9003169-A1
    优先权日:1988-09-28
    标题 :Synthesis of camptothecin and analogs thereof

    专利号:EP-0436653-A1
    优先权日:1988-09-28
    标 题:Synthesis of camptothecin and analogs thereof
    安徽立创生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.lichuangbio.com
    企业联系电话:13329263899;18856288893👤
    📞安徽立创生物科技有限公司 ⚠️参考联系方式
    联系人:凌总
    电话:13329263899;18856288893
    手机:13329263899;18856288893

    邮箱:lyj@lichuangbio.com
    通信地址: 安徽省铜陵市郊区枞阳县陈瑶湖清水路888号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:安徽省铜陵市郊区枞阳县陈瑶湖清水路888号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    河北松辰医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.summedchem.com
    企业联系电话:0319-5801333-808 0319-5801333-806👤
    📞河北松辰医药科技有限公司 ⚠️参考联系方式
    联系人:吴红松 李经理
    电话:0319-5801333-808 0319-5801333-806
    手机:15133182788;15630992918
    传真:0319-5801333-806
    邮箱:sales@summedchem.com
    通信地址: 河北省宁晋县西城工业聚集区天宝西街369号方大科技园C-7号楼
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:河北省宁晋县西城工业聚集区天宝西街369号方大科技园C-7号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Walker, J. C. L., Science of Synthesis: Knowledge Updates, (2024) 3, 221.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知